Darbepoetin alfa, an erythropoiesis-stimulating agent (ESA) used to treat renal anemia, might have anti-proteinuric effects in patients with diabetic kidney disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback